HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells.

Abstract
The copper(II) complex A0 induces a type of non-apoptotic cell death also known as paraptosis. Paraptosis involves extensive endoplasmic reticulum vacuolization in the absence of caspase activation. A wide panel of human cancer cell lines was used to demonstrate differences in cytotoxicity by the paraptosis-inducing drug A0 and the metal-based pro-apoptotic drug cisplatin. Gene expression profiling of the human fibrosarcoma HT1080 cells showed that, while cisplatin induced p53 targets, A0 up-regulated genes involved in the unfolded protein response (UPR) and response to heavy metals. The cytotoxic effects of A0 were associated with inhibition of the ubiquitin-proteasome system and accumulation of ubiquitinylated proteins, in a manner dependent on protein synthesis. Cycloheximide inhibited the accumulation of ubiquitinylated proteins and hampered A0-induced cell death process. The occurrence of the UPR during A0-induced death process was shown by the increased abundance of spliced XBP1 mRNA, transient eIF2alpha phosphorylation, and a series of downstream events, including attenuation of global protein synthesis and increased expression of ATF4, CHOP, BIP, and GADD34. Mouse embryonic fibroblasts expressing a mutant eIF2alpha, which could not be phosphorylated, were more resistant to A0 than wild type cells, pointing to a pro-death role of eIF2alpha phosphorylation. A0 may thus represent the prototypical member of a new class of compounds that cause paraptotic cell death via mechanisms involving eIF2alpha phosphorylation and the UPR.
AuthorsSaverio Tardito, Claudio Isella, Enzo Medico, Luciano Marchiò, Elena Bevilacqua, Maria Hatzoglou, Ovidio Bussolati, Renata Franchi-Gazzola
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 284 Issue 36 Pg. 24306-19 (Sep 04 2009) ISSN: 0021-9258 [Print] United States
PMID19561079 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Neoplasm Proteins
  • Organometallic Compounds
  • RNA, Messenger
  • Ubiquitin
  • Copper
  • Proteasome Endopeptidase Complex
  • Cisplatin
Topics
  • Animals
  • Antineoplastic Agents (pharmacology, therapeutic use)
  • Apoptosis (drug effects)
  • Caco-2 Cells
  • Cisplatin (pharmacology)
  • Copper (pharmacology, therapeutic use)
  • Drug Screening Assays, Antitumor
  • Endoplasmic Reticulum (genetics, metabolism)
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic (drug effects)
  • HeLa Cells
  • Humans
  • Mice
  • Neoplasm Proteins (biosynthesis, genetics)
  • Neoplasms (drug therapy, genetics, metabolism)
  • Organometallic Compounds (pharmacology, therapeutic use)
  • Proteasome Endopeptidase Complex (genetics, metabolism)
  • Protein Folding (drug effects)
  • RNA, Messenger (genetics, metabolism)
  • Stress, Physiological (drug effects)
  • Ubiquitin (genetics, metabolism)
  • Ubiquitination (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: